Chemotherapy, Cancer, Regional Perfusion
"Chemotherapy, Cancer, Regional Perfusion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part.
| Descriptor ID |
D010478
|
| MeSH Number(s) |
E02.319.267.200 E04.292.425
|
| Concept/Terms |
Chemotherapy, Cancer, Regional Perfusion- Chemotherapy, Cancer, Regional Perfusion
- Regional Perfusion Antineoplastic Chemotherapy
- Isolation Perfusion Cancer Chemotherapy
- Cancer Chemotherapy, Regional Perfusion
- Perfusion Cancer Chemotherapy, Regional
- Regional Perfusion Cancer Chemotherapy
|
Below are MeSH descriptors whose meaning is more general than "Chemotherapy, Cancer, Regional Perfusion".
Below are MeSH descriptors whose meaning is more specific than "Chemotherapy, Cancer, Regional Perfusion".
This graph shows the total number of publications written about "Chemotherapy, Cancer, Regional Perfusion" by people in this website by year, and whether "Chemotherapy, Cancer, Regional Perfusion" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 1 | 3 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemotherapy, Cancer, Regional Perfusion" by people in Profiles.
-
Morano WF, Khalili M, Chi DS, Bowne WB, Esquivel J. Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions-A systematic review. J Surg Oncol. 2018 Feb; 117(2):245-259.
-
Eagle RC, Shields CL, Bianciotto C, Jabbour P, Shields JA. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol. 2011 Nov; 129(11):1416-21.
-
Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, Rosenwasser R, Shields JA. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol. 2011 Nov; 129(11):1399-406.
-
Shields CL, Bianciotto CG, Jabbour P, Griffin GC, Ramasubramanian A, Rosenwasser R, Shields JA. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications. Arch Ophthalmol. 2011 Nov; 129(11):1407-15.
-
Sato T. Locoregional management of hepatic metastasis from primary uveal melanoma. Semin Oncol. 2010 Apr; 37(2):127-38.
-
Yamamoto A, Sato T. Locoregional treatment of malignant hepatic tumors with biologic response modifiers. Surg Oncol Clin N Am. 2008 Oct; 17(4):935-55, xii.
-
Gusani NJ, Cho SW, Colovos C, Seo S, Franko J, Richard SD, Edwards RP, Brown CK, Holtzman MP, Zeh HJ, Bartlett DL. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol. 2008 Mar; 15(3):754-63.
-
Brown DB, Cai SR, Fundakowski CE, Zamboni WC, Strychor S, McLeod HL. Pharmacokinetics after endovascular lung perfusion with Cisplatin. J Vasc Interv Radiol. 2006 May; 17(5):883-8.
-
Canter RJ, Zhou R, Kesmodel SB, Zhang Y, Heitjan DF, Glickson JD, Leeper DB, Fraker DL. Metaiodobenzylguanidine and hyperglycemia augment tumor response to isolated limb perfusion in a rodent model of human melanoma. Ann Surg Oncol. 2004 Mar; 11(3):265-73.
-
Brown DB, Ma MK, Battafarano RJ, Naidu S, Pluim D, Zamboni WC, McLeod HL. Endovascular lung perfusion using high-dose cisplatin: uptake and DNA adduct formation in an animal model. Oncol Rep. 2004 Jan; 11(1):237-43.